DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/vl8vvz/china_diabetes) has announced the addition of the "China Diabetes Management Devices Market Assessment and Forecast To 2019" report to their offering.
The Market Intelligence report provides critical market data for the China diabetes management devices market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level.
It's vital cross category comparison and cross sub-category comparison section makes analysis very handy for company professionals. The report helps professionals in mapping market size, competition, and understanding historic and future growth trends.
Scope
- Market Size
- Market Growth
- Competitive Analysis
- Pricing Analysis
- Recent Events and Developments
Diabetes Management Devices Market Segmentation
- Blood Glucose Monitoring Systems
- Blood Glucose Meters
- Blood Glucose Test Strips
- Continuous Glucose Monitoring Systems
- Continuous Glucose Monitors (CGM)
- CGM Sensors
- Insulin Delivery Devices
- Insulin Pens
- Reusable Insulin Pens
- Disposable Insulin Pens
- Insulin Syringes
- Insulin Pumps
Companies Mentioned
- Abbott Laboratories
- Animas Corporation
- Apex Biotechnology Corp.
- ARKRAY, Inc.
- AViTA Corporation
- Bayer HealthCare AG
- Becton, Dickinson and Company
- BIONIME Corporation
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- LifeScan, Inc.
- Medtronic, Inc.
- Novo Nordisk A/S
- San Meditech (Huzhou) Co., Ltd.
- Sanofi-Aventis
- Smiths Medical
- Terumo Corporation
For more information visit http://www.researchandmarkets.com/research/vl8vvz/china_diabetes.
